3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
4
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Mental Disorders
1
Lung Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Malignant Solid Neoplasm
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
X-Rays
1
Vincristine
1
Temozolomide
1
Technetium Tc 99m Sestamibi
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Behavior Therapy
×
90 days
×
Clear all
No trials found.